Gender-Specific Transfusion Affects Tumor-Associated Neutrophil: Macrophage Ratios in Murine Pancreatic Adenocarcinoma

Journal of Gastrointestinal Surgery

Volumn 14, Issue 10, 2010, Pages 1560-1565

  Benson, Douglas D ^a,b   Kelher, Marguerite R ^c   Meng, Xianzhong ^b   Fullerton, David A ^b   Lee, Joon H ^b   Silliman, Christopher C ^b,c   Barnett Jr , Carlton C ^a,b,c  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Bonfils Blood Center   (United States)

Author keywords

Erythrocytes; Immunomodulation; Metastasis; Neutrophil to macrophage ratio; Pancreas cancer; Transfusion

Indexed keywords

ADENOCARCINOMA; ANIMAL; ARTICLE; BLOOD TRANSFUSION; C57BL MOUSE; DISEASE MODEL; FEMALE; MACROPHAGE; MALE; MORTALITY; MOUSE; NEUTROPHIL; PANCREAS TUMOR; PERIOPERATIVE PERIOD; SEX DIFFERENCE; TUMOR MICROENVIRONMENT;

ADENOCARCINOMA; ANIMALS; BLOOD TRANSFUSION; DISEASE MODELS, ANIMAL; FEMALE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PANCREATIC NEOPLASMS; PERIOPERATIVE PERIOD; SEX FACTORS; TUMOR MICROENVIRONMENT;

EID: 77957021637     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-010-1329-1     Document Type: Article

References (32)

1. Yeh J, Gonen M, Tomlinson J, Indrees K, Brennan M, Fong Y. Effect of blood transfusion on outcome after pancreaticoduodenectomy for exocrine tumor of the pancreas. Br J Surg. 2007; 94: 466-72.
2. Park S, Kim S, Jang J, Lee K, Park Y. Intraoperative transfusions: Is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy? World J Surg. 2002; 26: 487-92.
3. Cameron J, Crist D, Sitzmann J, Hruben R, Boitnott J, Seidler A, Coleman J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg. 1991; 161: 120-5.
4. Millikan K, Deziel D, Silverstein J, Kanjo T, Christein J, Doolas A, Prinz R. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg. 1999; 65: 618-24.
5. Vamvakas E, Blajchman M. Transfusion-related immunomodulation (TRIM): an update. Blood Rev. 2007; 21(6): 327-48.
6. Opelz G, Senger D, Mickey M, Terasaki P. Effect of blood transfusion on subsequent kidney transplants. Transfusion Proc. 1973; 5: 253-9.
7. Gantt C. Red blood cells for cancer patients. Lancet. 1981; 363.
8. Breslin T, Hess K, Harbison D, Jean M, Cleary K, Dackiw A, Wolff R, Abbruzzese J, Janjan N, Crane C, Vauthey J, Lee J, Pisters P, Evans D. Neoadjuvant chemotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration. Ann Surg Oncol. 2001; 8: 123-32.
9. Conlon K, Klimstra D, Brennan M. Long-Term Survival After Curative Resection for Pancreatic Ductal Adenocarcinoma: Clinicopathologic Analysis of 5-Year Survivors. Ann Surg 1996; 223(3): 273-279.
10. Moore, P, Benson, D, Kelher, M, Moore, E, Fragoso, M, Silliman, C, Barnett, C. The plasma fraction of stored erythrocytes augments pancreatic cancer metastases in male versus female mice. J Surg Res. In Press.
11. Palfi M, Berg S, Emerudh J, Berlin G. A randomized Controlled Trail of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion. 2001; 41(3): 317-322.
12. Triulzi D. Transfusion-related acute lung injury: current concepts for the clinician. Anesth Analg. 2009; 108(3): 770-776.
13. Gajic O, Yilmaz M, Iscimen R, Kor D, Winters J, Moore S, Afessa B. Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit Care Med. 2007; 35(7): 1645-8.
14. Eder A, Herron R, Strupp A, Dy B, Notari E, Chambers L, Dodd R, Benjamin R. Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion. 2007; 47(4): 599-607.
15. Imoto S, Araki N, Shimada E, Saigo K, Nishimura K, Nose Y, Bouike Y, Hashimoto M, Mito H, Okazaki H. Comparison of acute non-haemolytic transfusion reactions in female and male patients receiving female or male blood components. Transfus Med. 2007; 17(6): 455-65.
16. Chapman C, Stainsby D, Jones H, Love E, Massey E, Win N, Navarrete C, Lucas G, Soni N, Morgan C, Choo L, Cohen H, Williamson L; Serious Hazards of Transfusion Steering Group. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2009; 49(3): 402-5.
17. Coussens L, Werb Z. Inflammation and cancer. Nature. 2002; 420: 860-7.
18. Pollard J. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004; 4: 71-8.
19. Nozawa H, Chui C, Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc Natl Acad Sci USA. 2006; 103: 12493-8.
20. Queen M, Ryan R, Holzer R, Keller-Peck C, Jorcyk C. Breast cancer cells stimulate neutrophils to produce oncostatin M: Potential implications for tumor progression. Cancer Res. 2005; 65: 8896-904.
21. Roland C, Dineen S, Toombs J, Carbon J, Smith C, Brekken R, Barnett C. Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreas xenografts. Exp Biol Med. 2010; 235: 263-70.
22. Technical Manual. American Association of Blood Banks, Bethesda. 2003.
23. Barnett C, Beck A, Holloway S, Kehler M, Schluterman M, Brekken R, Fleming J, Silliman C. Intravenous delivery of the plasma fraction of stored packed red cells promotes pancreatic cancer growth in immunocompetent mice. Cancer. In Press.
24. Animal Resources Body Weight Study of 1993. The Jackson Labs, 1993.
25. Zhang B, Wang J, Gao J, Guo Y, Chen X, Wang B, Gao J, Rao Z, Chen Z. Alternatively activated RAW264. 7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma. J Cell Bio. 2009; 107: 134-43.
26. Roland C, Harken A, Sarr M, Barnett C. ICAM-1 expression determines malignant potential of cancer. Surgery. 2007; 141: 705-7.
27. Strell C, Lang K, Niggemann B Zaenker K, Entschladen F. Neutrophil granulocytes promote the migratory activity of MDA-MB-468 human breast carcinoma cells via ICAM-1. Exp Cell Res. 2010; 316: 138-48.
28. Novais F, Santiago R, Bafica A, Khouri R, Afonso L, Borges V, Brodskyn C, Barral-Netto M, Barral A, de Oliveira C. Neutrophils and macrophages cooperate in host resistance against Leishmania braziliensis infection. J Immunol. 2009; 183: 8088-98.
29. Kishi Y, Kopetz S, Chun Y, Palavecino M, Abdalla E, Vauthey J. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol. 2009; 16: 614-22.
30. Lui H, Lui G, Bao Q, Sun W, Bao H, Bi L, Wen W, Lui Y, Wang Z, Yin X, Bai Y, Hu X. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in rectal carcinoma. J Gastrointest Cancer. 2010; Feb 2 Epub.
31. Halazun K, Aldoori A, Malik H, Al-Mukhtar A, Prasad K, Toogood G, Lodge J. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol. 2008; 34: 55-60.
32. Silliman C, Bjornsen J, Wyman T, Kelher M, Allard J, Bieber S, Voelkel N. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion. 2003; 43: 633-40.